Emilie Gauthy

Company: Zelluna Immunotherapy

Job title: Head of Chemistry, Manufacturing & Controls

Seminars:

Streamlining Manufacturing of TCR-NK Cells to Unlock the Benefits of Dual Targeting Allogeneic Cell Therapies 2:00 pm

• Overview of Zelluna’s development of TCR-NK cells combining TCR specificity with innate NK activation • Discussing scalable manufacturing approaches to integrate TCR and NK cell production • Examining challenges and opportunities to translate novel TCR-NK cell platforms to widespread clinical useRead more

day: Day Two